SCHEMBL13973310

SCHEMBL13973310

CCNCc1cccc(Oc2ccc(Cl)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.57
▸ HTT P42858 3/20 0.57
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ LMNA P02545 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ MAPK1 P28482 1/20 0.47
▸ PPARG P37231 1/20 0.47
▸ PPARA Q07869 1/20 0.47
▸ DRD2 P14416 1/20 0.44
▸ DRD4 P21917 1/20 0.44
▸ CHRM2 P08172 1/20 0.43
▸ FDFT1 P37268 1/20 0.43
▸ FAAH O00519 1/20 0.42
▸ FFAR1 O14842 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13973346 0.88 ALDH1A1 (0.50) ALDH1A1HTTSMN1; SMN2KDM4ELMNA
SCHEMBL8278009 0.87 KDM4E (0.68) ALDH1A1HTTSMN1; SMN2KDM4EMEN1
SCHEMBL13973034 0.87 ALDH1A1 (0.52) ALDH1A1HTTSMN1; SMN2KDM4EMEN1
SCHEMBL14266673 0.86 KDM4E (0.76) ALDH1A1HTTSMN1; SMN2KDM4EMEN1
SCHEMBL13973181 0.86 ALDH1A1 (0.58) ALDH1A1HTTSMN1; SMN2KDM4EMEN1
SCHEMBL14149848 0.86 SMN1; SMN2 (0.54) ALDH1A1HTTSMN1; SMN2KDM4ELMNA
SCHEMBL13948890 0.84 ALDH1A1 (0.55) ALDH1A1HTTSMN1; SMN2KDM4ELMNA
SCHEMBL13406682 0.83 ALDH1A1 (0.59) ALDH1A1HTTSMN1; SMN2KDM4ELMNA
SCHEMBL30821649 0.82 LMNA (0.54) ALDH1A1HTTSMN1; SMN2KDM4ELMNA
SCHEMBL8241107 0.82 ALDH1A1 (0.62) ALDH1A1HTTSMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090011977-A1 Novel Lipopeptides as Antibacterial Agents HILL JASON 2009-01-08 — — US disclosed
US-7408025-B2 Lipopeptides as antibacterial agents CUBIST PHARMACEUTICALS, INC. (US) 2008-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090011977-A1 Novel Lipopeptides as Antibacterial Agents CLPTM1, NGLY1, VIP ALDH1A1 4742/4885HTT 2832/4885SMN1; SMN2 4753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback